* What about Australians under the age of 16?
The Pfizer vaccination approval does not cover people under the age of 16, but it has no upper age limit. The medical regulator says the benefits of the vaccination for people over the age of 85, or those who are frail, should be weighed against potential risk of even a mild response.
Age limits for the AstraZeneca vaccination will be outlined in the Therapeutic Goods Administration’s approval.
* How many do we get?
Both vaccines are two doses – so Australians will get two at least 21 days apart. They will need to be from the same company.
* Where will they be administered?
General practitioners and pharmacies have put their hand up to be involved, and there’s expected to be pop-up clinics at current COVID-19 testing centres and hospitals.
* How can Australians prove they’ve been vaccinated?
Jabs will be recorded on the Australian Immunisation Register. Certificates proving vaccinations will then be available either digitally or in hard copy. The government says this might be needed for interstate and overseas travel.
* How many vaccines has Australia ordered?
Australia has secured more than 150 million doses of various vaccines, including almost 54 million doses of the AstraZeneca vaccine, with the vast majority to be manufactured in Melbourne. As well as more than 51 million from Novavax.
WHICH VACCINES AUSTRALIA HAS SECURED:
Pfizer:
20 million doses – enough to vaccinate 10 million Australians
Novavax:
Australia has ordered 51 million doses but it is still in the trial phase
University of Oxford/AstraZeneca:
53.8 million doses
3.8 million doses to be delivered to Australia in early 2021
COVAX Facility
The Australian Government has joined the COVAX Facility as part of a global effort to support rapid, fair and equitable access to COVID-19 vaccines. This participation enables us to purchase vaccine doses for Australia as they become available
This includes the Moderna vaccine, CureVac, Inovio and others.
Australia has paid $123.2 million to allow the purchase of over 25,000,000 doses and paid $80 million to support vaccine access for
University of Queensland:
Australia had ordered 51 million doses. However, the deal has been scrapped after trial participants returned false positive results for HIV
